Baló concentric sclerosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:228165G37.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Baló concentric sclerosis (BCS), also known as Baló disease or concentric periaxial leukoencephalopathy, is a rare and aggressive demyelinating disorder of the central nervous system. It is considered a variant of multiple sclerosis (MS) and is characterized by the distinctive formation of alternating rings of demyelinated and myelinated white matter in the brain, creating a concentric or onion-like pattern visible on MRI or at pathological examination. The disease primarily affects the brain's white matter, though lesions can also occur in the brainstem and spinal cord. Clinical presentation is variable but often includes rapidly progressive neurological symptoms such as headache, cognitive dysfunction, behavioral changes, aphasia (difficulty with language), seizures, hemiparesis (weakness on one side of the body), and visual disturbances. Some patients experience a fulminant, monophasic course leading to severe disability or death within weeks to months, while others may follow a relapsing-remitting course more similar to typical MS. The disease most commonly affects young to middle-aged adults, with cases reported across diverse ethnic backgrounds, though it has been noted with particular frequency in populations from the Philippines and China. There is no established standard treatment for Baló concentric sclerosis due to its rarity. Management strategies are largely extrapolated from multiple sclerosis treatment protocols and typically include high-dose intravenous corticosteroids during acute episodes. Plasma exchange (plasmapheresis) has been used in steroid-refractory cases with some reported benefit. Immunosuppressive agents and disease-modifying therapies used in MS, such as mitoxantrone or natalizumab, have been tried in individual cases. Prognosis is highly variable; while historically considered a rapidly fatal condition, improved neuroimaging has led to recognition of milder cases, and some patients experience partial or even substantial recovery.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Baló concentric sclerosis.

View clinical trials →

No actively recruiting trials found for Baló concentric sclerosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Baló concentric sclerosis community →

No specialists are currently listed for Baló concentric sclerosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Baló concentric sclerosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Baló concentric sclerosisForum →

No community posts yet. Be the first to share your experience with Baló concentric sclerosis.

Start the conversation →

Latest news about Baló concentric sclerosis

No recent news articles for Baló concentric sclerosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Baló concentric sclerosis

What is Baló concentric sclerosis?

Baló concentric sclerosis (BCS), also known as Baló disease or concentric periaxial leukoencephalopathy, is a rare and aggressive demyelinating disorder of the central nervous system. It is considered a variant of multiple sclerosis (MS) and is characterized by the distinctive formation of alternating rings of demyelinated and myelinated white matter in the brain, creating a concentric or onion-like pattern visible on MRI or at pathological examination. The disease primarily affects the brain's white matter, though lesions can also occur in the brainstem and spinal cord. Clinical presentation

How is Baló concentric sclerosis inherited?

Baló concentric sclerosis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Baló concentric sclerosis typically begin?

Typical onset of Baló concentric sclerosis is adult. Age of onset can vary across affected individuals.